Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by R. Nandy
Evolving Epidemiology of Poliovirus Serotype 2 Following Withdrawal of the Type 2 Oral Poliovirus Vaccine
Science
Multidisciplinary
Philosophy of Science
History
Related publications
Implementation of Coordinated Global Serotype 2 Oral Poliovirus Vaccine Cessation: Risks of Potential Non-Synchronous Cessation
BMC Infectious Diseases
Infectious Diseases
Notes From the Field: Detection of Sabin-Like Type 2 Poliovirus From Sewage After Global Cessation of Trivalent Oral Poliovirus Vaccine — Hyderabad and Ahmedabad, India, August–September 2016
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology
First Report of a Persistent Oropharyngeal Infection of Type 2 Vaccine-Derived Poliovirus (iVDPV2) in a Primary Immune Deficient (PID) Patient After Eradication of Wild Type 2 Poliovirus
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt From 1983 to 1993
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Prolonged Excretion of Type-2 Poliovirus From a Primary Immune Deficient Patient During the Transition to a Type-2 Poliovirus-Free World, Israel, 2016
Eurosurveillance
Environmental
Virology
Public Health
Epidemiology
Medicine
Occupational Health
Evolution of the Vp1 Region Type 2 Vaccine-Derived Poliovirus Shedding From an Immunocompromised Algerian Child
Russian Journal of Infection and Immunity
Infectious Diseases
Allergy
Immunology
Comparative Epidemiology of Poliovirus Transmission
Scientific Reports
Multidisciplinary
Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)
Epidemiology and Vaccine Prevention
Poliovirus-Binding Inhibition ELISA for Evaluation of Immune Response to Oral Poliovirus Vaccine: A Possible Alternative to the Neutralization Test
Human Vaccines
